While quantitative and semi-quantitative immunohistochemical (IHC) assessment of CD8+ TIL in melanoma has been reported in several studies17,27; there remains no standardized method to assess CD8+ TIL and hence, each study analyzed CD8+ TIL differently. The gene discussed is CD8A; the disease is melanoma.